The latest price target for Clorox (NYSE:CLX) was reported by Barclays on February 5, 2025. The analyst firm set a price target for $140.00 expecting CLX to fall to within 12 months (a possible -10.94% downside). 42 analyst firms have reported ratings in the last year.

The latest analyst rating for Clorox (NYSE:CLX) was provided by Barclays, and Clorox maintained their underweight rating.

The last upgrade for Clorox Co happened on January 7, 2025 when Wells Fargo raised their price target to $157. Wells Fargo previously had an underweight for Clorox Co.

The last downgrade for Clorox Co happened on April 2, 2024 when Citigroup changed their price target from $170 to $165 for Clorox Co.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Clorox, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Clorox was filed on February 5, 2025 so you should expect the next rating to be made available sometime around February 5, 2026.

While ratings are subjective and will change, the latest Clorox (CLX) rating was a maintained with a price target of $130.00 to $140.00. The current price Clorox (CLX) is trading at is $157.19, which is out of the analyst’s predicted range.